Gulf Funds Agree to Back Paramount's Takeover of Warner; Netflix Upgraded; Neurocrine to Buy Soleno Therapeutics

Today's biggest winners and losers in the stock market.

On this episode of Stock Movers:

- Gulf Funds Agree to Back Paramount's $81 Billion Takeover of Warner

- Netflix (NFLX) shares are up after Goldman Sachs upgraded the streaming-video company to buy from neutral.

- Neurocrine Biosciences agreed to buy Soleno Therapeutics for $2.9 billion to expand in rare genetic disorders. The biotechnology company will pay $53 per share for Soleno, a 34% premium to its closing share price Thursday, using cash on hand and some pre-payable debt. Both company boards have approved the transaction, which is expected to close within 90 days.

See omnystudio.com/listener for privacy information.